Literature DB >> 10619861

In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA.

P Soussan1, F Garreau, H Zylberberg, C Ferray, C Brechot, D Kremsdorf.   

Abstract

Hepatitis B virus (HBV) is a small DNA virus with a compact genomic organization. All HBV proteins identified to date have been encoded by unspliced HBV RNAs. Spliced HBV RNAs have been described, but their functions are unknown. We show here that a singly spliced HBV RNA encodes a novel HBV protein in vivo. This HBV splice-generated protein (HBSP) corresponds to the fusion of a part of the viral polymerase and a new open reading frame that is created by the splicing event. In vivo, HBSP protein was found in HBV-infected liver samples, and anti-HBSP antibodies occurred in one-third of sera samples collected from chronic HBV carriers. In vitro, the ectopic expression of HBSP had no effect on viral DNA replication or transcription but induced cell apoptosis without a cell-cycle block. Overall, our results suggest that HBV has evolved a mechanism that directly modulates virus-cell interaction through RNA splicing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10619861      PMCID: PMC382588          DOI: 10.1172/JCI8098

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

Review 1.  Viruses and apoptosis.

Authors:  V O'Brien
Journal:  J Gen Virol       Date:  1998-08       Impact factor: 3.891

2.  A splice hepadnavirus RNA that is essential for virus replication.

Authors:  S Obert; B Zachmann-Brand; E Deindl; W Tucker; R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

Review 3.  Regulation of apoptosis by viral gene products.

Authors:  J G Teodoro; P E Branton
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 4.  The molecular biology of the hepatitis B viruses.

Authors:  D Ganem; H E Varmus
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  An evolutionarily conserved splice generates a secreted env-Bet fusion protein during human foamy virus infection.

Authors:  M L Giron; H de Thé; A Saïb
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Heterogeneity and common features of defective hepatitis B virus genomes derived from spliced pregenomic RNA.

Authors:  S Günther; G Sommer; A Iwanska; H Will
Journal:  Virology       Date:  1997-11-24       Impact factor: 3.616

7.  Detection and mapping of spliced RNA from a human hepatoma cell line transfected with the hepatitis B virus genome.

Authors:  T Suzuki; N Masui; K Kajino; I Saito; T Miyamura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

8.  In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA.

Authors:  O Rosmorduc; M A Petit; S Pol; F Capel; F Bortolotti; P Berthelot; C Brechot; D Kremsdorf
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

Review 9.  Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis.

Authors:  F V Chisari
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

10.  Temporal aspects of major viral transcript expression in Hep G2 cells transfected with cloned hepatitis B virus DNA: with emphasis on the X transcript.

Authors:  H L Wu; P J Chen; M H Lin; D S Chen
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

View more
  40 in total

1.  In vitro and in vivo interactions between the hepatitis B virus protein P22 and the cellular protein gC1qR.

Authors:  S Lainé; A Thouard; J Derancourt; M Kress; D Sitterlin; J-M Rossignol
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Biological impacts of "hot-spot" mutations of hepatitis B virus X proteins are genotype B and C differentiated.

Authors:  Xu Lin; Xiao Xu; Qing-Ling Huang; Yu-Qing Liu; Da-Li Zheng; Wan-Nan Chen; Jian-Yin Lin
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

Review 3.  Molecular mechanisms underlying HBsAg negativity in occult HBV infection.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-24       Impact factor: 3.267

Review 4.  Overview of hepatitis B viral replication and genetic variability.

Authors:  Shuping Tong; Peter Revill
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

Review 5.  Hepatocellular carcinoma and hepatitis B surface protein.

Authors:  Yong-Wei Li; Feng-Cai Yang; Hui-Qiong Lu; Jiong-Shan Zhang
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

6.  Interaction of the hepatitis B spliced protein with cathepsin B promotes hepatoma cell migration and invasion.

Authors:  Wan-Nan Chen; Jin-Yan Chen; Bo-Yan Jiao; Wan-Song Lin; Yun-Li Wu; Ling-Ling Liu; Xu Lin
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

Review 7.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

8.  Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice.

Authors:  Zhihua Qi; Gaiyun Li; Hao Hu; Chunhui Yang; Xiaoming Zhang; Qibin Leng; Youhua Xie; Demin Yu; Xinxin Zhang; Yueqiu Gao; Ke Lan; Qiang Deng
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

Review 9.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

10.  Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance.

Authors:  Scott Preiss; Margaret Littlejohn; Peter Angus; Alex Thompson; Paul Desmond; Sharon R Lewin; Joe Sasadeusz; Gail Matthews; Gregory J Dore; Tim Shaw; Vitini Sozzi; Lilly Yuen; George Lau; Anna Ayres; Chloe Thio; Anchalee Avihingsanon; Kiat Ruxrungtham; Stephen Locarnini; Peter A Revill
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.